Literature DB >> 25528334

Improving selectivity preserving affinity: new piperidine-4-carboxamide derivatives as effective sigma-1-ligands.

Daniele Zampieri1, Erik Laurini2, Luciano Vio3, Maurizio Fermeglia2, Sabrina Pricl4, Bernhard Wünsch5, Dirk Schepmann5, Maria Grazia Mamolo3.   

Abstract

We report the design, synthesis and binding evaluation against σ1 and σ2 receptors of a series of new piperidine-4-carboxamide derivatives variously substituted on the amide nitrogen atom. Specifically, we assessed the effects exerted on σ receptor affinity by substituting the N-benzylcarboxamide group present on a series of compounds previously synthesized in our laboratory with different cyclic or linear moieties. The synthesized compounds 2a-o were tested to estimate their affinity and selectivity toward σ1 and σ2 receptors. Very high σ1 affinity (Ki = 3.7 nM) and Kiσ2/Kiσ1 selectivity ratio (351) were found for the tetrahydroquinoline derivative 2k, featuring a 4-chlorobenzyl moiety linked to the piperidine nitrogen atom.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Piperidine-4-carboxamide derivatives; Radioligand binding assays; σ-Receptors

Mesh:

Substances:

Year:  2014        PMID: 25528334     DOI: 10.1016/j.ejmech.2014.12.018

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations.

Authors:  Mateusz Kurciński; Małgorzata Jarończyk; Piotr F J Lipiński; Jan Cz Dobrowolski; Joanna Sadlej
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

2.  Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptors.

Authors:  Winnie Deuther-Conrad; Daniel Diez-Iriepa; Isabel Iriepa; Francisco López-Muñoz; María Angeles Martínez-Grau; Michael Gütschow; José Marco-Contelles
Journal:  RSC Med Chem       Date:  2021-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.